Maitri Porecha - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Maitri Porecha's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Maitri Porecha
Verified
Correspondent, DNA India
Mumbai
Beats
freelancing,health parenting, psychology wellness, motherhood mental health, relationships
Content
By Maitri Porecha Verified| The Hindu Business Line Verified The Drug Controller General of India (DCGI) has instructed pharma major Biocon to revise its clinical trial protocol for conducting phase-4 studies on Itolizumab used to treat Covid-19 patients. Itolizumab, a drug used in a skin condition, Psoriasis, is now being re-purposed for treating Covid patients. Re-purposing a drug means prescribing it for newer indications; in this case for Covid, other than what the drug is usually used for.
Drug controller instructs Serum Institute to revise protocol for Oxford Covid-19 vaccine clinical trial
By Maitri Porecha Verified| The Hindu Business Line Verified The Drug Controller General of India (DCGI) has instructed Pune-based Serum Institute of India (SII) to submit a revised protocol for conducting clinical trials in India for the Covid-19 vaccine candidate developed by the University of Oxford. SII has signed an agreement with British-Swedish multinational AstraZeneca to manufacture the ChAdOx1 nCoV-19 coronavirus vaccine doses if the trials are successful.
By Maitri Porecha Verified| The Hindu Business Line Verified The Drug Controller General of India (DCGI) has instructed pharma major Biocon to revise its clinical trial protocol for conducting phase-4 studies on Itolizumab used to treat Covid-19 patients. Itolizumab, a drug used in a skin condition, Psoriasis, is now being re-purposed for treating Covid patients. Re-purposing a drug means prescribing it for newer indications; in this case for Covid, other than what the drug is usually used for.
Company Info
DNA India
DNA - Daily News & Analysis is an Indian English-language broadsheet newspaper published by Diligent Media Corporation. Founded in 2005, it serves cities such as Mumbai, Ahmedabad, Pune, Jaipur, Bangalore, and Indore. The newspaper covers a wide range of topics, including news and current affairs, and is known for its journalism. In addition to its print publication, DNA operates a digital news platform that provides online news and breaking news coverage. The company is involved in media production, content creation, and publishing, catering to both print and digital audiences. With an annual revenue reported between 150 to 250 crores, DNA employs around 414 people as of February 2025.
+91 22398 88888
Founded: 2005